No Data
Buchang Pharmaceuticals Gets Drug Registration for Donepezil Hydrochloride Tablets
Shandong Buchang Pharmaceuticals (603858.SH): Signed a pharmaceutical registration clinical trial entrustment contract.
Gelonghui December 3rd | Shandong Buchang Pharmaceuticals (603858.SH) announced that the company signed a "Contract Entrusting Beijing Zhuoyue Future International Pharmaceutical Technology Development Co., Ltd." (referred to as "Beijing Zhuoyue") for the registration clinical trial of Shenfu Yixin Granule, entrusting Beijing Zhuoyue to complete the registration clinical trial of Shenfu Yixin Granule. The total price of the registration clinical trial for this project is 55,338,000.00 yuan (including taxes). This time the company signed a "Contract Entrusting Registration Clinical Trial of Shenfu Yixin Granule" with a third party, which is beneficial for expanding the company's pharmaceutical R&D capabilities and scope, to some extent saving the time and cost of the company's pharmaceutical clinical trials.
Shandong Buchang Pharmaceuticals Passes GMP Compliance for Meihekou, China Production Line
Shandong Buchang Pharmaceuticals (603858.SH) wholly-owned subsidiary received the pharmaceutical GMP compliance inspection results.
shandong buchang pharmaceuticals (603858.SH) announced that the company has learned that its wholly-owned subsidiary, Tonghua Guhong Pharmaceuticals Co., Ltd. (referred to as "...
Buchang Pharmaceuticals to Invest 11 Million Yuan to Set Up Six Subsidiaries
shandong buchang pharmaceuticals (603858.SH): planning to jointly invest a total of 11.13 million yuan to establish six holding subsidiaries.
GeLongHui November 22nd | Shandong Buchang Pharmaceuticals (603858.SH) announced that in order to improve the global strategy development layout, gain market competitive advantage on the basis of refined management, promote business development, and plan to invest a total of 11.13 million yuan to set up six holding subsidiaries, namely Shandong Buchang Chuanfang Pharmaceutical Co., Ltd., Buchang Lianchuang Trading Co., Ltd., Buchang Dingxin Trading Co., Ltd., Buchang Mailitong Trading Co., Ltd., Buchang Zhongfu Shou Pharmaceutical Co., Ltd., and Shandong Buchang Ruifeng Technology Co., Ltd. (subject to industrial and commercial registration). In order to promote a win-win situation for the company and all parties' interests, for the company and
Shandong Buchang Pharmaceuticals (SHSE:603858) Shareholders Have Endured a 15% Loss From Investing in the Stock Three Years Ago
No Data
